FDA Approves ACETAMINOPHEN AND CODEINE PHOSPHATE — Elite Laboratories, Inc.
Elite Laboratories, Inc. secured FDA approval for its generic Acetaminophen and Codeine Phosphate tablets (ANDA 212418), opening a pathway to capture market share in the established pain management sector. The launch of this generic alternative is anticipated to bolster the company's revenue growth and broaden its existing product portfolio.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day